3Lentsch AB. The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A roleas clear as black and while [J]. FASEB J, 2002, 16(9):1093-1095.
4Yamazaki K,Yano T,Kameyama T,et al.Clinical significance of serum TH1/TH2 cytokines in patients with pulmonary adenocarcinoma.Surgery,2002,131(1 Suppl):S236-S241.
5Ikeda H,Chamoto K,Tsuji T,et al.The critical role of type-1 innate and acquired immunity in tumor immunotherapy.Cancer Sci,2004,95:697-703.
6Heuser C,Diehl V,Abken H,et al.Anti-CD30-IL-12 antibody-cytokine fusion protein that induces IFN-gamma secretion of T cells and NK cell-mediated lysis of Hodgkin' s lymphomaderived tumor cells.Int J Cancer,2003,106:545-552.
7Li Q,Carr AL,Donald EJ,et al.Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern.Cancer Res,2005,65:1063-1070.
8Suzuki T,Fukuhara T,Tanaka M,et al.Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity:characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.Clin Cancer Res,2005,11:58-66.
9Liu KJ,Lu LF,Cheng HT,et al,Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.Cancer Gene Ther,2004,11:135-147.
10Iinuma H,Okinaga K,Fukushima R,et al.Reduction of immunosuppression and shift to Th1 response by tumor-DC (dendritic cells) fusion vaccine.Gan To Kagaku Ryoho,2004,31:1640-1642.
